Accueil>>Signaling Pathways>> Ubiquitination/ Proteasome>> Autophagy>>Maprotiline HCl

Maprotiline HCl (Synonyms: Ba 34276)

Catalog No.GC12376

Maprotiline HCl est un inhibiteur sélectif de la recapture de la noradrénaline et un antidépresseur tétracyclique.

Products are for research use only. Not for human use. We do not sell to patients.

Maprotiline HCl Chemical Structure

Cas No.: 10347-81-6

Taille Prix Stock Qté
10mM (in 1mL DMSO)
34,00 $US
En stock
50mg
52,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Maprotiline hydrochloride is a selective noradrenalin re-uptake inhibitor and a tetracyclic antidepressant.Target: OthersMaprotiline (sold as Deprilept, Ludiomil, Psymion) is a tetracyclic antidepressant (TeCA). However, Maprotiline's fourth ring is spurious, as formed by a bridge across the central tricyclic ring. It is a strong norepinephrine reuptake inhibitor with only weak effects on serotonin and dopamine reuptake. It exerts strong blocking effect at H1 receptors, moderate at 5-HT2 and alpha1 and weak blocking effect at D2 and mACh postsynaptic receptors [1, 2].

References:
[1]. Peng, W.H., et al., Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice. Life Sci, 2007. 81(11): p. 933-8.
[2]. http://en.wikipedia.org/wiki/Maprotiline

Avis

Review for Maprotiline HCl

Average Rating: 5 ★★★★★ (Based on Reviews and 26 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Maprotiline HCl

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.